title: Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
abstract: The introduction of highly active antiretroviral therapy (HAART) has changed the natural history of AIDS-associated Kaposi's sarcoma (KS). Although the use of HAART remains limited in low-resource settings, there are global initiatives to make these drugs available to several millions of HIV-infected persons. While there are multiple reports of KS regression during HAART with or without chemotherapy, there is little documentation on KS management in resource-limited settings. In this paper we review current KS treatments available worldwide and discuss the implications of the increased access to antiretrovirals for KS treatment strategies in resource-limited settings.
authors.affiliation: Clinical Sciences Department, Institute of Tropical Medicine, Antwerp, Belgium. llynen@itg.be
authors.forename: Lut
authors.initials: L
authors.lastname: Lynen
authors.forename: Maria
authors.initials: M
authors.lastname: Zolfo
authors.forename: Veerle
authors.initials: V
authors.lastname: Huyst
authors.forename: Francoise
authors.initials: F
authors.lastname: Louis
authors.forename: Pieter
authors.initials: P
authors.lastname: Barnardt
authors.forename: Ann
authors.initials: A
authors.lastname: Van de Velde
authors.forename: Caroline
authors.initials: C
authors.lastname: De Schacht
authors.forename: Robert
authors.initials: R
authors.lastname: Colebunders
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D003906:Developing Countries; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D012514:Sarcoma, Kaposi / Q000150:complications / Q000188:drug therapy*